SAFETY DATA SHEET Version 6.
18
Revision Date 04.03.2024
according to Regulation (EC) No. 1907/2006 Print Date 13.07.2024
SECTION 1: Identification of the substance/mixture and of the company/undertaking
1.1 Product identifiers
Product name : Tetrahydrofuran
Product Number : 401757
Brand : Sigma-Aldrich
Index-No. : 603-025-00-0
REACH No. : 01-2119444314-46-XXXX
CAS-No. : 109-99-9
1.2 Relevant identified uses of the substance or mixture and uses advised against
Identified uses : Laboratory chemicals, Manufacture of substances
1.3 Details of the supplier of the safety data sheet
Company : Merck Life Science UK Limited
New Road
The Old Brickyard
GILLINGHAM
Dorset
SP8 4XT
UNITED KINGDOM
Telephone : +44 (0)1747 833-000
Fax : +44 (0)1747 833-313
E-mail address : TechnicalService@merckgroup.com
1.4 Emergency telephone
Emergency Phone # : +44 (0)870 8200418 (CHEMTREC)
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 as amended by GB-CLP
Regulation, UK SI 2019/720, and UK SI 2020/1567
Flammable liquids, (Category 2) H225: Highly flammable liquid and vapor.
Acute toxicity, (Category 4) H302: Harmful if swallowed.
Eye irritation, (Category 2) H319: Causes serious eye irritation.
Sigma-Aldrich- 401757 Page 1 of 24
The life science business of Merck operates as MilliporeSigma in the US and
Canada
Carcinogenicity, (Category 2) H351: Suspected of causing cancer.
Specific target organ toxicity - H336: May cause drowsiness or dizziness.
single exposure, (Category 3),
Central nervous system
Specific target organ toxicity - H335: May cause respiratory irritation.
single exposure, (Category 3),
Respiratory system
2.2 Label elements
Labelling according Regulation (EC) No 1272/2008 as amended by GB-CLP
Regulation, UK SI 2019/720, and UK SI 2020/1567
Pictogram
Signal Word Danger
Hazard Statements
H225 Highly flammable liquid and vapor.
H302 Harmful if swallowed.
H319 Causes serious eye irritation.
H335 May cause respiratory irritation.
H336 May cause drowsiness or dizziness.
H351 Suspected of causing cancer.
Precautionary Statements
P202 Do not handle until all safety precautions have been read and
understood.
P210 Keep away from heat, hot surfaces, sparks, open flames and
other ignition sources. No smoking.
P233 Keep container tightly closed.
P301 + P312 IF SWALLOWED: Call a POISON CENTER/ doctor if you feel
unwell.
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes.
Remove contact lenses, if present and easy to do. Continue
rinsing.
P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Supplemental Hazard information (EU)
EUH019 May form explosive peroxides.
Reduced Labeling (<= 125 ml)
Pictogram
Signal Word Danger
Hazard Statements
H351 Suspected of causing cancer.
Precautionary Statements
P202 Do not handle until all safety precautions have been read and
Sigma-Aldrich- 401757 Page 2 of 24
The life science business of Merck operates as MilliporeSigma in the US and
Canada
understood.
P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Supplemental Hazard information (EU)
EUH019 May form explosive peroxides.
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent,
bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at
levels of 0.1% or higher.
Ecological information:
The substance/mixture does not contain components considered to have endocrine
disrupting properties according to REACH Article 57(f) or Commission Delegated regulation
(EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
Toxicological information:
The substance/mixture does not contain components considered to have endocrine
disrupting properties according to REACH Article 57(f) or Commission Delegated regulation
(EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
SECTION 3: Composition/information on ingredients
3.1 Substances
Synonyms : THF
Formula : C4H8O
Molecular weight : 72.11 g/mol
CAS-No. : 109-99-9
EC-No. : 5-53
Index-No. : 603-025-00-0
Component Classification Concentration
Tetrahydrofuran
CAS-No. 109-99-9 Flam. Liq. 2; Acute Tox. 4; <= 100 %
EC-No. 5-53 Eye Irrit. 2; Carc. 2; STOT
Index-No. 603-025-00-0 SE 3; H225, H302, H319,
H351, H336, H335
Concentration limits:
>= 25 %: Eye Irrit. 2,
H319; >= 25 %: STOT SE
3, H335;
For the full text of the H-Statements mentioned in this Section, see Section 16.
SECTION 4: First aid measures
4.1 Description of first-aid measures
General advice
Show this material safety data sheet to the doctor in attendance.
If inhaled
After inhalation: fresh air. Call in physician.
Sigma-Aldrich- 401757 Page 3 of 24
The life science business of Merck operates as MilliporeSigma in the US and
Canada
In case of skin contact
In case of skin contact: Take off immediately all contaminated clothing. Rinse skin with
water/ shower. Consult a physician.
In case of eye contact
After eye contact: rinse out with plenty of water. Call in ophthalmologist. Remove contact
lenses.
If swallowed
After swallowing: immediately make victim drink water (two glasses at most). Consult a
physician.
4.2 Most important symptoms and effects, both acute and delayed
The most important known symptoms and effects are described in the labelling (see section
2.2) and/or in section 11
4.3 Indication of any immediate medical attention and special treatment needed
No data available
SECTION 5: Firefighting measures
5.1 Extinguishing media
Suitable extinguishing media
Carbon dioxide (CO2) Foam Dry powder
Unsuitable extinguishing media
For this substance/mixture no limitations of extinguishing agents are given.
5.2 Special hazards arising from the substance or mixture
Carbon oxides
Combustible.
Pay attention to flashback.
Vapors are heavier than air and may spread along floors.
Development of hazardous combustion gases or vapours possible in the event of fire.
Forms explosive mixtures with air at ambient temperatures.
5.3 Advice for firefighters
Stay in danger area only with self-contained breathing apparatus. Prevent skin contact by
keeping a safe distance or by wearing suitable protective clothing.
5.4 Further information
Remove container from danger zone and cool with water. Prevent fire extinguishing water
from contaminating surface water or the ground water system.
SECTION 6: Accidental release measures
6.1 Personal precautions, protective equipment and emergency procedures
Advice for non-emergency personnel: Do not breathe vapors, aerosols. Avoid substance
contact. Ensure adequate ventilation. Keep away from heat and sources of ignition.
Evacuate the danger area, observe emergency procedures, consult an expert.
For personal protection see section 8.
6.2 Environmental precautions
Do not let product enter drains. Risk of explosion.
Sigma-Aldrich- 401757 Page 4 of 24
The life science business of Merck operates as MilliporeSigma in the US and
Canada
6.3 Methods and materials for containment and cleaning up
Cover drains. Collect, bind, and pump off spills. Observe possible material restrictions
(see sections 7 and 10). Take up carefully with liquid-absorbent material (e.g.
Chemizorb®). Dispose of properly. Clean up affected area.
6.4 Reference to other sections
For disposal see section 13.
SECTION 7: Handling and storage
7.1 Precautions for safe handling
Advice on safe handling
Work under hood. Do not inhale substance/mixture. Avoid generation of vapours/aerosols.
Advice on protection against fire and explosion
Keep away from open flames, hot surfaces and sources of ignition.Take precautionary
measures against static discharge.
Hygiene measures
Immediately change contaminated clothing. Apply preventive skin protection. Wash hands
and face after working with substance.
For precautions see section 2.2.
7.2 Conditions for safe storage, including any incompatibilities
Storage conditions
Keep container tightly closed in a dry and well-ventilated place. Keep away from heat and
sources of ignition.
Test for peroxide formation periodically and before distillation.
Storage class
Storage class (TRGS 510): 3: Flammable liquids
7.3 Specific end use(s)
Apart from the uses mentioned in section 1.2 no other specific uses are stipulated
SECTION 8: Exposure controls/personal protection
8.1 Control parameters
Ingredients with workplace control parameters
Component CAS-No. Control Value Basis
parameter
s
Tetrahydrofuran 109-99-9 TWA 50 ppm Europe. Commission Directive
150 mg/m3 2000/39/EC establishing a first
list of indicative occupational
exposure limit values
Remarks Identifies the possibility of significant uptake through the
skin
Indicative
Sigma-Aldrich- 401757 Page 5 of 24
The life science business of Merck operates as MilliporeSigma in the US and
Canada
STEL 100 ppm Europe. Commission Directive
300 mg/m3 2000/39/EC establishing a first
list of indicative occupational
exposure limit values
Identifies the possibility of significant uptake through the
skin
Indicative
TWA 50 ppm UK. EH40 WEL - Workplace
150 mg/m3 Exposure Limits
Can be absorbed through the skin. The assigned substances
are those for which there are concerns that dermal
absorption will lead to systemic toxicity.
STEL 100 ppm UK. EH40 WEL - Workplace
300 mg/m3 Exposure Limits
Can be absorbed through the skin. The assigned substances
are those for which there are concerns that dermal
absorption will lead to systemic toxicity.
Derived No Effect Level (DNEL)
Application Area Routes of Health effect Value
exposure
Workers Skin contact Long-term systemic effects 25mg/kg BW/d
Consumers Skin contact Long-term systemic effects 15mg/kg BW/d
Workers Inhalation Long-term local effects 150 mg/m3
Workers Inhalation Long-term systemic effects 150 mg/m3
Consumers Inhalation Long-term systemic effects 62 mg/m3
Consumers Inhalation Acute local effects 150 mg/m3
Consumers Inhalation Acute systemic effects 150 mg/m3
Predicted No Effect Concentration (PNEC)
Compartment Value
Soil 2.13 mg/kg
Sea water 0.432 mg/l
Fresh water 4.32 mg/l
Sea sediment 2.33 mg/kg
Fresh water sediment 23.3 mg/kg
Onsite sewage treatment plant 4.6 mg/l
8.2 Exposure controls
Personal protective equipment
Eye/face protection
Use equipment for eye protection tested and approved under appropriate
government standards such as NIOSH (US) or EN 166(EU). Safety glasses
Skin protection
This recommendation applies only to the product stated in the safety data sheet,
supplied by us and for the designated use. When dissolving in or mixing with other
substances and under conditions deviating from those stated in EN 16523-1 please
Sigma-Aldrich- 401757 Page 6 of 24
The life science business of Merck operates as MilliporeSigma in the US and
Canada
contact the supplier of CE-approved gloves (e.g. KCL GmbH, D-36124 Eichenzell,
Internet: www.kcl.de).
Splash contact
Material: butyl-rubber
Minimum layer thickness: 0.7 mm
Break through time: 10 min
Material tested:Butoject® (KCL 898)
Body Protection
Flame retardant antistatic protective clothing.
Respiratory protection
Recommended Filter type: Filter A (acc. to DIN 3181) for vapours of organic
compounds
The entrepeneur has to ensure that maintenance, cleaning and testing of respiratory
protective devices are carried out according to the instructions of the producer.
These measures have to be properly documented.
Control of environmental exposure
Do not let product enter drains. Risk of explosion.
SECTION 9: Physical and chemical properties
9.1 Information on basic physical and chemical properties
a) Physical state liquid
b) Color No data available
c) Odor No data available
d) Melting Melting point: -108.44 °C - (ECHA)
point/freezing point
e) Initial boiling point 65 °C at 1,013.25 hPa - (ECHA)
and boiling range
f) Flammability (solid, No data available
gas)
g) Upper/lower Upper explosion limit: 12.4 %(V) - (THF)
flammability or Lower explosion limit: 1.5 %(V)
explosive limits
h) Flash point -21.2 °C - closed cup - DIN 51755 Part 1
i) Autoignition 215 °C
temperature at 1,013 hPa - DIN 51794
j) Decomposition No data available
temperature
k) pH ca.7 - 8
l) Viscosity Viscosity, kinematic: No data available
Viscosity, dynamic: 0.359 mPa.s at 50 °C0.456 mPa.s at 25 °C
m) Water solubility miscible
n) Partition coefficient: log Pow: 0.45 at 25 °C - Bioaccumulation is not expected.
Sigma-Aldrich- 401757 Page 7 of 24
The life science business of Merck operates as MilliporeSigma in the US and
Canada
n-octanol/water
o) Vapor pressure 170 hPa at 20 °C - (THF)
p) Density 0.89 g/cm3 at 20 °C
Relative density No data available
q) Relative vapor No data available
density
r) Particle No data available
characteristics
s) Explosive properties No data available
t) Oxidizing properties none
9.2 Other safety information
No data available
SECTION 10: Stability and reactivity
10.1 Reactivity
Formation of peroxides possible.
Vapors may form explosive mixture with air.
10.2 Chemical stability
Sensitivity to light
Sensitive to air.
The product is chemically stable under standard ambient conditions (room temperature) .
Stable under recommended storage conditions.
10.3 Possibility of hazardous reactions
No data available
10.4 Conditions to avoid
Distillation (Risk of explosion).
Warming.
Moisture.
10.5 Incompatible materials
No data available
10.6 Hazardous decomposition products
Peroxides
In the event of fire: see section 5
SECTION 11: Toxicological information
11.1 Information on toxicological effects
Acute toxicity
LD50 Oral - Rat - male and female - 1,650 mg/kg
Remarks: (ECHA)
Symptoms: Irritation of mucous membranes
Sigma-Aldrich- 401757 Page 8 of 24
The life science business of Merck operates as MilliporeSigma in the US and
Canada
Acute toxicity estimate Oral - 1,650 mg/kg
(ATE value derived from LD50/LC50 value)
LC50 Inhalation - Rat - male and female - 6 h - > 14.7 mg/l - vapor
(US-EPA)
LD50 Dermal - Rat - male and female - > 2,000 mg/kg
(OECD Test Guideline 402)
Skin corrosion/irritation
Skin - Rabbit
Result: No skin irritation - 72 h
(Draize Test)
Remarks: Repeated or prolonged exposure may cause skin irritation and dermatitis, due to
degreasing properties of the product.
Serious eye damage/eye irritation
Eyes - Rabbit
Result: Causes serious eye irritation.
Remarks: (IUCLID)
Remarks: Classified according to Regulation (EU) 1272/2008, Annex VI (Table 3.1/3.2)
Respiratory or skin sensitization
Local lymph node assay (LLNA) - Mouse
Result: negative
(OECD Test Guideline 429)
Germ cell mutagenicity
Test Type: Ames test
Test system: S. typhimurium
Metabolic activation: with and without metabolic activation
Method: OECD Test Guideline 471
Result: negative
Test Type: In vitro mammalian cell gene mutation test
Test system: Chinese hamster ovary cells
Metabolic activation: with and without metabolic activation
Method: OECD Test Guideline 476
Result: negative
Test Type: Chromosome aberration test in vitro
Test system: Chinese hamster ovary cells
Metabolic activation: with and without metabolic activation
Method: OECD Test Guideline 473
Result: negative
Test Type: Micronucleus test
Species: Mouse
Cell type: Red blood cells (erythrocytes)
Application Route: inhalation (vapor)
Method: OECD Test Guideline 474
Result: negative
Carcinogenicity
Suspected of causing cancer.
Reproductive toxicity
No data available
Sigma-Aldrich- 401757 Page 9 of 24
The life science business of Merck operates as MilliporeSigma in the US and
Canada
Specific target organ toxicity - single exposure
Inhalation - May cause respiratory irritation. - Central nervous system
Remarks: Classified according to Regulation (EU) 1272/2008, Annex VI (Table 3.1/3.2)
May cause drowsiness or dizziness.
Specific target organ toxicity - repeated exposure
No data available
Aspiration hazard
No data available
11.2 Additional Information
Endocrine disrupting properties
Product:
Assessment : The substance/mixture does not contain
components considered to have endocrine
disrupting properties according to REACH Article
57(f) or Commission Delegated regulation (EU)
2017/2100 or Commission Regulation (EU)
2018/605 at levels of 0.1% or higher.
Repeated dose toxicity - Rat - male and female - Oral - 4 Weeks
RTECS: LU5950000
irritant effects, Cough, Shortness of breath, narcosis, somnolence
To the best of our knowledge, the chemical, physical, and toxicological properties have not
been thoroughly investigated.
In high doses:
somnolence
narcosis
Other dangerous properties can not be excluded.
This substance should be handled with particular care.
SECTION 12: Ecological information
12.1 Toxicity
Toxicity to fish flow-through test LC50 - Pimephales promelas (fathead minnow) -
2,160 mg/l - 96 h
(OECD Test Guideline 203)
Toxicity to daphnia static test EC50 - Daphnia magna (Water flea) - 3,485 mg/l - 48 h
and other aquatic (OECD Test Guideline 202)
invertebrates
Toxicity to flow-through test NOEC - Pimephales promelas (fathead minnow) -
fish(Chronic toxicity) 216 mg/l - 33 d
Remarks: (ECHA)
Sigma-Aldrich- 401757 Page 10 of 24
The life science business of Merck operates as MilliporeSigma in the US and
Canada
12.2 Persistence and degradability
Biodegradability aerobic Biochemical oxygen demand - Exposure time 28 d
Result: 39 % - Not readily biodegradable.
(OECD Test Guideline 301D)
12.3 Bioaccumulative potential
No data available
12.4 Mobility in soil
No data available
12.5 Results of PBT and vPvB assessment
This substance/mixture contains no components considered to be either persistent,
bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at
levels of 0.1% or higher.
12.6 Endocrine disrupting properties
Product:
Assessment : The substance/mixture does not contain components
considered to have endocrine disrupting properties
according to REACH Article 57(f) or Commission
Delegated regulation (EU) 2017/2100 or Commission
Regulation (EU) 2018/605 at levels of 0.1% or higher.
12.7 Other adverse effects
No data available
SECTION 13: Disposal considerations
13.1 Waste treatment methods
Product
Waste material must be disposed of in accordance with the national and local regulations.
Leave chemicals in original containers. No mixing with other waste. Handle uncleaned
containers like the product itself. See www.retrologistik.com for processes regarding the
return of chemicals and containers, or contact us there if you have further questions.
Notice Directive on waste 2008/98/EC.
SECTION 14: Transport information
14.1 UN number
ADR/RID: 2056 IMDG: 2056 IATA: 2056
14.2 UN proper shipping name
ADR/RID: TETRAHYDROFURAN
IMDG: TETRAHYDROFURAN
IATA: Tetrahydrofuran
Sigma-Aldrich- 401757 Page 11 of 24
The life science business of Merck operates as MilliporeSigma in the US and
Canada
14.3 Transport hazard class(es)
ADR/RID: 3 IMDG: 3 IATA: 3
14.4 Packaging group
ADR/RID: II IMDG: II IATA: II
14.5 Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
14.6 Special precautions for user
Tunnel restriction code : (D/E)
Further information : No data available
SECTION 15: Regulatory information
15.1 Safety, health and environmental regulations/legislation specific for the
substance or mixture
This material safety data sheet complies with the requirements of Regulation (EC) No.
1907/2006.
Authorisations and/or restrictions on use
National legislation
Seveso III: Directive 2012/18/EU of the P5c FLAMMABLE LIQUIDS
European Parliament and of the Council
on the control of major-accident hazards
involving dangerous substances.
Other regulations
Observe work restrictions regarding maternity protection in accordance to Dir 92/85/EEC or
stricter national regulations where applicable.
Take note of Dir 94/33/EC on the protection of young people at work.
15.2 Chemical Safety Assessment
A Chemical Safety Assessment has been carried out for this substance.
SECTION 16: Other information
Full text of H-Statements
H225 Highly flammable liquid and vapor.
H302 Harmful if swallowed.
H319 Causes serious eye irritation.
H335 May cause respiratory irritation.
H336 May cause drowsiness or dizziness.
H351 Suspected of causing cancer.
EUH019 May form explosive peroxides.
Sigma-Aldrich- 401757 Page 12 of 24
The life science business of Merck operates as MilliporeSigma in the US and
Canada
Full text of other abbreviations
ADN - European Agreement concerning the International Carriage of Dangerous Goods
by Inland Waterways; ADR - Agreement concerning the International Carriage of
Dangerous Goods by Road; AIIC - Australian Inventory of Industrial Chemicals; ASTM -
American Society for the Testing of Materials; bw - Body weight; CMR - Carcinogen,
Mutagen or Reproductive Toxicant; DIN - Standard of the German Institute for
Standardisation; DSL - Domestic Substances List (Canada); ECx - Concentration
associated with x% response; ELx - Loading rate associated with x% response; EmS -
Emergency Schedule; ENCS - Existing and New Chemical Substances (Japan); ErCx -
Concentration associated with x% growth rate response; GHS - Globally Harmonized
System; GLP - Good Laboratory Practice; IARC - International Agency for Research on
Cancer; IATA - International Air Transport Association; IBC - International Code for the
Construction and Equipment of Ships carrying Dangerous Chemicals in Bulk; IC50 - Half
maximal inhibitory concentration; ICAO - International Civil Aviation Organization;
IECSC - Inventory of Existing Chemical Substances in China; IMDG - International
Maritime Dangerous Goods; IMO - International Maritime Organization; ISHL - Industrial
Safety and Health Law (Japan); ISO - International Organisation for Standardization;
KECI - Korea Existing Chemicals Inventory; LC50 - Lethal Concentration to 50 % of a
test population; LD50 - Lethal Dose to 50% of a test population (Median Lethal Dose);
MARPOL - International Convention for the Prevention of Pollution from Ships; n.o.s. -
Not Otherwise Specified; NO(A)EC - No Observed (Adverse) Effect Concentration;
NO(A)EL - No Observed (Adverse) Effect Level; NOELR - No Observable Effect Loading
Rate; NZIoC - New Zealand Inventory of Chemicals; OECD - Organization for Economic
Co-operation and Development; OPPTS - Office of Chemical Safety and Pollution
Prevention; PBT - Persistent, Bioaccumulative and Toxic substance; PICCS - Philippines
Inventory of Chemicals and Chemical Substances; (Q)SAR - (Quantitative) Structure
Activity Relationship; REACH - Regulation (EC) No 1907/2006 of the European
Parliament and of the Council concerning the Registration, Evaluation, Authorisation and
Restriction of Chemicals; RID - Regulations concerning the International Carriage of
Dangerous Goods by Rail; SADT - Self-Accelerating Decomposition Temperature; SDS -
Safety Data Sheet; TCSI - Taiwan Chemical Substance Inventory; TECI - Thailand
Existing Chemicals Inventory; TSCA - Toxic Substances Control Act (United States); UN
- United Nations; UNRTDG - United Nations Recommendations on the Transport of
Dangerous Goods; vPvB - Very Persistent and Very Bioaccumulative
Further information
The information is believed to be correct but is not exhaustive and will be used solely as
a guideline, which is based on current knowledge of the chemical substance or mixture
and is applicable to appropriate safety precautions for the product. It does not represent
any guarantee of the properties of the product. Sigma-Aldrich Corporation and its
Affiliates shall not be held liable for any damage resulting from handling or from contact
with the above product. See www.sigma-aldrich.com and/or the reverse side of invoice
or packing slip for additional terms and conditions of sale.
Copyright 2020 Sigma-Aldrich Co. LLC. License granted to make unlimited paper copies
for internal use only.
The branding on the header and/or footer of this document may temporarily not visually match
the product purchased as we transition our branding. However, all of the information in the
document regarding the product remains unchanged and matches the product ordered. For
further information please contact mlsbranding@sial.com.
Sigma-Aldrich- 401757 Page 13 of 24
The life science business of Merck operates as MilliporeSigma in the US and
Canada
Sigma-Aldrich- 401757 Page 14 of 24
The life science business of Merck operates as MilliporeSigma in the US and
Canada
Annex: Exposure scenario
Identified uses:
Use: Used as chemical intermediate
SU 3: Industrial uses: Uses of substances as such or in preparations at industrial sites
SU 3, SU9: Industrial uses: Uses of substances as such or in preparations at industrial sites,
Manufacture of fine chemicals
PC19: Intermediate
PROC1: Use in closed process, no likelihood of exposure
PROC2: Use in closed, continuous process with occasional controlled exposure
PROC3: Use in closed batch process (synthesis or formulation)
PROC4: Use in batch and other process (synthesis) where opportunity for exposure arises
PROC8b: Transfer of substance or preparation (charging/ discharging) from/ to vessels/
large containers at dedicated facilities
PROC15: Use as laboratory reagent
ERC1: Manufacture of substances
Use: Formulation of preparations
SU 3: Industrial uses: Uses of substances as such or in preparations at industrial sites
SU 10: Formulation [mixing] of preparations and/ or re-packaging (excluding alloys)
PROC2: Use in closed, continuous process with occasional controlled exposure
PROC3: Use in closed batch process (synthesis or formulation)
PROC4: Use in batch and other process (synthesis) where opportunity for exposure arises
PROC5: Mixing or blending in batch processes for formulation of preparations and articles
(multistage and/ or significant contact)
PROC8b: Transfer of substance or preparation (charging/ discharging) from/ to vessels/
large containers at dedicated facilities
PROC9: Transfer of substance or preparation into small containers (dedicated filling line,
including weighing)
PROC14: Production of preparations or articles by tabletting, compression, extrusion,
pelletization
PROC15: Use as laboratory reagent
ERC2: Formulation of preparations
Use: Industrial use of processing aids in processes and products, not becoming
part of articles
SU 3: Industrial uses: Uses of substances as such or in preparations at industrial sites
SU 3, SU9: Industrial uses: Uses of substances as such or in preparations at industrial sites,
Manufacture of fine chemicals
PC20: Products such as pH-regulators, flocculants, precipitants, neutralization agents
PC21: Laboratory chemicals
PROC1: Use in closed process, no likelihood of exposure
PROC2: Use in closed, continuous process with occasional controlled exposure
PROC3: Use in closed batch process (synthesis or formulation)
PROC4: Use in batch and other process (synthesis) where opportunity for exposure arises
PROC8b: Transfer of substance or preparation (charging/ discharging) from/ to vessels/
large containers at dedicated facilities
PROC9: Transfer of substance or preparation into small containers (dedicated filling line,
Sigma-Aldrich- 401757 Page 15 of 24
The life science business of Merck operates as MilliporeSigma in the US and
Canada
including weighing)
PROC10: Roller application or brushing
PROC15: Use as laboratory reagent
ERC4, ERC6b: Industrial use of processing aids in processes and products, not becoming
part of articles, Industrial use of reactive processing aids
Use: Used as laboratory reagent.
SU 22: Professional uses: Public domain (administration, education, entertainment,
services, craftsmen)
SU 3, SU 22, SU24: Industrial uses: Uses of substances as such or in preparations at
industrial sites, Professional uses: Public domain (administration, education, entertainment,
services, craftsmen), Scientific research and development
PC21: Laboratory chemicals
PROC15: Use as laboratory reagent
ERC2, ERC6a, ERC6b: Formulation of preparations, Industrial use resulting in manufacture
of another substance (use of intermediates), Industrial use of reactive processing aids
1. Short title of Exposure Scenario: Used as chemical intermediate
Main User Groups : SU 3
Sectors of end-use : SU 3, SU9
Chemical product category : PC19
Process categories : PROC1, PROC2, PROC3, PROC4, PROC8b, PROC15
Environmental Release Categories : ERC1:
2. Exposure scenario
2.1 Contributing scenario controlling environmental exposure for: ERC1
Product characteristics
Concentration of the Substance in : Covers the percentage of the substance in the product
Mixture/Article up to 100 % (unless stated differently).
2.2 Contributing scenario controlling worker exposure for: PROC1, PROC2, PROC3,
PROC4, PROC8b, PROC15, PC19
Product characteristics
Concentration of the Substance in : Covers the percentage of the substance in the product
Mixture/Article up to 100 % (unless stated differently).
Physical Form (at time of use) : High volatile liquid
Frequency and duration of use
Sigma-Aldrich- 401757 Page 16 of 24
The life science business of Merck operates as MilliporeSigma in the US and
Canada
Application duration : >4h
Frequency of use : 220 days/year
Other operational conditions affecting workers exposure
Outdoor / Indoor : Indoor
Technical conditions and measures
Use only in area provided with appropriate exhaust ventilation., Good work practice
required.
Organizational measures to prevent /limit releases, dispersion and exposure
Ensure operatives are trained to minimize exposures.
Conditions and measures related to personal protection, hygiene and health
evaluation
Wear suitable gloves tested to EN374., For personal protection see section 8.
3. Exposure estimation and reference to its source
Environment
A chemical safety assessment was performed according REACH Article 14(3), Annex I,
sections 3 (Environmental Hazard assessment) and 4 (PBT/vPvB Assessment). As no
hazard was identified, an exposure assessment and risk characterisation is not necessary
(REACH Annex I section 5.0).
Workers
Contributin Exposure Specific Value Level of RCR*
g Scenario Assessment conditions Exposure
Method
PROC1 ECETOC TRA With Local Dermal 0.34 mg/kg 0.014
Exhaust BW/d
Ventilation
PROC1 ECETOC TRA With Local Inhalation 0 mg/m³ 0
Exhaust
Ventilation
PROC2 ECETOC TRA With Local Inhalation 15.023 0.1
Exhaust mg/m³
Ventilation
PROC2 ECETOC TRA With Local Dermal 0.14 mg/kg 0.006
Exhaust BW/d
Ventilation
PROC3 ECETOC TRA With Local Inhalation 30.046 0.2
Exhaust mg/m³
Ventilation
PROC3 ECETOC TRA With Local Dermal 0.034 mg/kg 0.001
Exhaust BW/d
Ventilation
PROC4 ECETOC TRA With Local Dermal 0.686 mg/kg 0.027
Exhaust BW/d
Ventilation
PROC4 ECETOC TRA With Local Inhalation 30.046 0.2
Sigma-Aldrich- 401757 Page 17 of 24
The life science business of Merck operates as MilliporeSigma in the US and
Canada
Exhaust mg/m³
Ventilation
PROC8b ECETOC TRA With Local Dermal 0.69 mg/kg 0.028
Exhaust BW/d
Ventilation
PROC8b ECETOC TRA With Local Inhalation 13.521 0.09
Exhaust mg/m³
Ventilation
PROC15 ECETOC TRA With Local Dermal 0.03 mg/kg 0.001
Exhaust BW/d
Ventilation
PROC15 ECETOC TRA With Local Inhalation 30.046 0.2
Exhaust mg/m³
Ventilation
*Risk characterisation ratio
4. Guidance to Downstream User to evaluate whether he works inside the boundaries
set by the Exposure Scenario
Please refer to the following documents: ECHA Guidance on information requirements and
chemical safety assessment Part D: Exposure Scenario Building, Part E: Risk
Characterisation and Part G: Extending the SDS; VCI/Cefic REACH Practical Guides on
Exposure Assessment and Communications in the Supply Chain; CEFIC Guidance Specific
Environmental Release Categories (SPERCs).
1. Short title of Exposure Scenario: Formulation of preparations
Main User Groups : SU 3
Sectors of end-use : SU 10
Process categories : PROC2, PROC3, PROC4, PROC5, PROC8b, PROC9,
PROC14, PROC15
Environmental Release Categories : ERC2:
2. Exposure scenario
2.1 Contributing scenario controlling environmental exposure for: ERC2
Product characteristics
Concentration of the Substance in : Covers the percentage of the substance in the product
Mixture/Article up to 100 % (unless stated differently).
2.2 Contributing scenario controlling worker exposure for: PROC2, PROC3, PROC4,
PROC5, PROC8b, PROC9, PROC14, PROC15
Product characteristics
Concentration of the Substance in : Covers the percentage of the substance in the product
Mixture/Article up to 100 % (unless stated differently).
Physical Form (at time of use) : High volatile liquid
Frequency and duration of use
Application duration : >4h
Frequency of use : 220 days/year
Sigma-Aldrich- 401757 Page 18 of 24
The life science business of Merck operates as MilliporeSigma in the US and
Canada
Other operational conditions affecting workers exposure
Outdoor / Indoor : Indoor
Technical conditions and measures
Use only in area provided with appropriate exhaust ventilation., Good work practice
required.
Organizational measures to prevent /limit releases, dispersion and exposure
Ensure operatives are trained to minimize exposures.
Conditions and measures related to personal protection, hygiene and health
evaluation
Wear suitable gloves tested to EN374., For personal protection see section 8.
3. Exposure estimation and reference to its source
Environment
A chemical safety assessment was performed according REACH Article 14(3), Annex I,
sections 3 (Environmental Hazard assessment) and 4 (PBT/vPvB Assessment). As no
hazard was identified, an exposure assessment and risk characterisation is not necessary
(REACH Annex I section 5.0).
Workers
Contributin Exposure Specific Value Level of RCR*
g Scenario Assessment conditions Exposure
Method
PROC2 ECETOC TRA With Local Dermal 0.14 mg/kg 0.006
Exhaust BW/d
Ventilation
PROC2 ECETOC TRA With Local Inhalation 15.023 0.1
Exhaust mg/m³
Ventilation
PROC3 ECETOC TRA With Local Dermal 0.034 mg/kg 0.001
Exhaust BW/d
Ventilation
PROC3 ECETOC TRA With Local Inhalation 30.046 0.2
Exhaust mg/m³
Ventilation
PROC4 ECETOC TRA With Local Dermal 0.686 mg/kg 0.027
Exhaust BW/d
Ventilation
PROC4 ECETOC TRA With Local Inhalation 30.046 0.2
Exhaust mg/m³
Ventilation
PROC5 ECETOC TRA With Local Inhalation 75.115 0.501
Exhaust mg/m³
Ventilation
PROC5 ECETOC TRA With Local Dermal 0.069 mg/kg 0.003
Exhaust BW/d
Ventilation
PROC8b ECETOC TRA With Local Inhalation 13.521 0.09
Sigma-Aldrich- 401757 Page 19 of 24
The life science business of Merck operates as MilliporeSigma in the US and
Canada
Exhaust mg/m³
Ventilation
PROC8b ECETOC TRA With Local Dermal 0.69 mg/kg 0.028
Exhaust BW/d
Ventilation
PROC9 ECETOC TRA With Local Dermal 0.69 mg/kg 0.028
Exhaust BW/d
Ventilation
PROC9 ECETOC TRA With Local Inhalation 60.092 0.401
Exhaust mg/m³
Ventilation
PROC14 ECETOC TRA With Local Dermal 0.34 mg/kg 0.014
Exhaust BW/d
Ventilation
PROC14 ECETOC TRA With Local Inhalation 75.115 0.501
Exhaust mg/m³
Ventilation
PROC15 ECETOC TRA With Local Inhalation 30.046 0.2
Exhaust mg/m³
Ventilation
PROC15 ECETOC TRA With Local Dermal 0.03 mg/kg 0.001
Exhaust BW/d
Ventilation
*Risk characterisation ratio
4. Guidance to Downstream User to evaluate whether he works inside the boundaries
set by the Exposure Scenario
Please refer to the following documents: ECHA Guidance on information requirements and
chemical safety assessment Part D: Exposure Scenario Building, Part E: Risk
Characterisation and Part G: Extending the SDS; VCI/Cefic REACH Practical Guides on
Exposure Assessment and Communications in the Supply Chain; CEFIC Guidance Specific
Environmental Release Categories (SPERCs).
1. Short title of Exposure Scenario: Industrial use of processing aids in processes and
products, not becoming part of articles
Main User Groups SU 3 :
Sectors of end-use SU 3, SU9 :
Chemical product category PC20, PC21 :
Process categories :
PROC1, PROC2, PROC3, PROC4, PROC8b, PROC9,
PROC10, PROC15
Environmental Release Categories : ERC4, ERC6b:
2. Exposure scenario
2.1 Contributing scenario controlling environmental exposure for: ERC4, ERC6b
Product characteristics
Concentration of the Substance in : Covers the percentage of the substance in the product
Mixture/Article up to 100 % (unless stated differently).
Sigma-Aldrich- 401757 Page 20 of 24
The life science business of Merck operates as MilliporeSigma in the US and
Canada
2.2 Contributing scenario controlling worker exposure for: PROC1, PROC2, PROC3,
PROC4, PROC8b, PROC9, PROC10, PROC15, PC20, PC21
Product characteristics
Concentration of the Substance in : Covers the percentage of the substance in the product
Mixture/Article up to 100 % (unless stated differently).
Physical Form (at time of use) : High volatile liquid
Frequency and duration of use
Application duration : >4h
Frequency of use : 220 days/year
Other operational conditions affecting workers exposure
Outdoor / Indoor : Indoor
Technical conditions and measures
Use only in area provided with appropriate exhaust ventilation., Good work practice
required.
Organizational measures to prevent /limit releases, dispersion and exposure
Ensure operatives are trained to minimize exposures.
Conditions and measures related to personal protection, hygiene and health
evaluation
Wear suitable gloves tested to EN374., For personal protection see section 8.
3. Exposure estimation and reference to its source
Environment
A chemical safety assessment was performed according REACH Article 14(3), Annex I,
sections 3 (Environmental Hazard assessment) and 4 (PBT/vPvB Assessment). As no
hazard was identified, an exposure assessment and risk characterisation is not necessary
(REACH Annex I section 5.0).
Workers
Contributin Exposure Specific Value Level of RCR*
g Scenario Assessment conditions Exposure
Method
PROC1 ECETOC TRA With Local Dermal 0.34 mg/kg 0.014
Exhaust BW/d
Ventilation
PROC1 ECETOC TRA With Local Inhalation 0 mg/m³ 0
Exhaust
Ventilation
PROC2 ECETOC TRA With Local Inhalation 15.023 0.1
Exhaust mg/m³
Ventilation
PROC2 ECETOC TRA With Local Dermal 0.14 mg/kg 0.006
Exhaust BW/d
Ventilation
PROC3 ECETOC TRA With Local Inhalation 30.046 0.2
Exhaust mg/m³
Sigma-Aldrich- 401757 Page 21 of 24
The life science business of Merck operates as MilliporeSigma in the US and
Canada
Ventilation
PROC3 ECETOC TRA With Local Dermal 0.034 mg/kg 0.001
Exhaust BW/d
Ventilation
PROC4 ECETOC TRA With Local Dermal 0.686 mg/kg 0.027
Exhaust BW/d
Ventilation
PROC4 ECETOC TRA With Local Inhalation 30.046 0.2
Exhaust mg/m³
Ventilation
PROC8b ECETOC TRA With Local Inhalation 13.521 0.09
Exhaust mg/m³
Ventilation
PROC8b ECETOC TRA With Local Dermal 0.69 mg/kg 0.028
Exhaust BW/d
Ventilation
PROC9 ECETOC TRA With Local Dermal 0.69 mg/kg 0.028
Exhaust BW/d
Ventilation
PROC9 ECETOC TRA With Local Inhalation 60.092 0.401
Exhaust mg/m³
Ventilation
PROC10 ECETOC TRA With Local Dermal 1.371 mg/kg 0.055
Exhaust BW/d
Ventilation
PROC10 ECETOC TRA With Local Inhalation 75.115 0.501
Exhaust mg/m³
Ventilation
PROC15 ECETOC TRA With Local Inhalation 30.046 0.2
Exhaust mg/m³
Ventilation
PROC15 ECETOC TRA With Local Dermal 0.03 mg/kg 0.001
Exhaust BW/d
Ventilation
*Risk characterisation ratio
4. Guidance to Downstream User to evaluate whether he works inside the boundaries
set by the Exposure Scenario
Please refer to the following documents: ECHA Guidance on information requirements and
chemical safety assessment Part D: Exposure Scenario Building, Part E: Risk
Characterisation and Part G: Extending the SDS; VCI/Cefic REACH Practical Guides on
Exposure Assessment and Communications in the Supply Chain; CEFIC Guidance Specific
Environmental Release Categories (SPERCs).
1. Short title of Exposure Scenario: Used as laboratory reagent.
Main User Groups : SU 22
Sectors of end-use : SU 3, SU 22, SU24
Chemical product category : PC21
Process categories : PROC15
Sigma-Aldrich- 401757 Page 22 of 24
The life science business of Merck operates as MilliporeSigma in the US and
Canada
Environmental Release Categories : ERC2, ERC6a, ERC6b:
2. Exposure scenario
2.1 Contributing scenario controlling environmental exposure for: ERC2, ERC6a, ERC6b
Product characteristics
Concentration of the Substance in : Covers the percentage of the substance in the product
Mixture/Article up to 100 % (unless stated differently).
2.2 Contributing scenario controlling worker exposure for: PROC15, PC21
Product characteristics
Concentration of the Substance in : Covers the percentage of the substance in the product
Mixture/Article up to 100 % (unless stated differently).
Physical Form (at time of use) : High volatile liquid
Frequency and duration of use
Application duration : >4h
Frequency of use : 220 days/year
Other operational conditions affecting workers exposure
Outdoor / Indoor : Indoor
Technical conditions and measures
Use only in area provided with appropriate exhaust ventilation., Good work practice
required.
Organizational measures to prevent /limit releases, dispersion and exposure
Ensure operatives are trained to minimize exposures.
Conditions and measures related to personal protection, hygiene and health
evaluation
Wear suitable gloves tested to EN374., For personal protection see section 8.
3. Exposure estimation and reference to its source
Environment
A chemical safety assessment was performed according REACH Article 14(3), Annex I,
sections 3 (Environmental Hazard assessment) and 4 (PBT/vPvB Assessment). As no
hazard was identified, an exposure assessment and risk characterisation is not necessary
(REACH Annex I section 5.0).
Workers
Contributin Exposure Specific Value Level of RCR*
g Scenario Assessment conditions Exposure
Method
PROC15 ECETOC TRA With Local Dermal 0.03 mg/kg 0.001
Exhaust BW/d
Ventilation
PROC15 ECETOC TRA With Local Inhalation 30.046 0.2
Exhaust mg/m³
Ventilation
*Risk characterisation ratio
Sigma-Aldrich- 401757 Page 23 of 24
The life science business of Merck operates as MilliporeSigma in the US and
Canada
4. Guidance to Downstream User to evaluate whether he works inside the boundaries
set by the Exposure Scenario
Please refer to the following documents: ECHA Guidance on information requirements and
chemical safety assessment Part D: Exposure Scenario Building, Part E: Risk
Characterisation and Part G: Extending the SDS; VCI/Cefic REACH Practical Guides on
Exposure Assessment and Communications in the Supply Chain; CEFIC Guidance Specific
Environmental Release Categories (SPERCs).
Sigma-Aldrich- 401757 Page 24 of 24
The life science business of Merck operates as MilliporeSigma in the US and
Canada